Prophylactic HPV vaccines
Copyright policy )Prophylactic HPV vaccines
The HPV L1 VLP vaccines are immensely important developments in public health and the benefits that they promise are immense, offering the opportunity to prevent, in the long term, 80% of cervical cancers, 60% of vulval cancers and 80% of anal cancers in women. In the short to medium term they will prevent at least 90% of genital warts and have a major impact on the incidence of high grade CIN, thus reducing the number of women who have to undergo LEEP and LLETZ. The health economic benefits will be substantial but the overwhelming benefit is the major improvement for human health and well-being. (
- University of Cambridge United Kingdom
Male, Patient Selection, Papillomavirus Infections, Uterine Cervical Neoplasms, Cancer Vaccines, Risk Factors, Animals, Humans, Mass Screening, Female, Papillomavirus Vaccines, Genital Diseases, Female, Papillomaviridae
Male, Patient Selection, Papillomavirus Infections, Uterine Cervical Neoplasms, Cancer Vaccines, Risk Factors, Animals, Humans, Mass Screening, Female, Papillomavirus Vaccines, Genital Diseases, Female, Papillomaviridae
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).44 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!